These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26421858)

  • 1. [Hallucinogen Persisting Perception Disorder (HPPD) and Flashback Phenomena – Differential Diagnosis and Explanation Models].
    Hermle L; Ruchsow M; Täschner KL
    Fortschr Neurol Psychiatr; 2015 Sep; 83(9):506-15. PubMed ID: 26421858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hallucinogen-induced psychological disorders].
    Hermle L; Kovar KA; Hewer W; Ruchsow M
    Fortschr Neurol Psychiatr; 2008 Jun; 76(6):334-42. PubMed ID: 18512184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.
    Lerner AG; Gelkopf M; Skladman I; Oyffe I; Finkel B; Sigal M; Weizman A
    Isr J Psychiatry Relat Sci; 2002; 39(2):92-9. PubMed ID: 12227234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD.
    Halpern JH; Lerner AG; Passie T
    Curr Top Behav Neurosci; 2018; 36():333-360. PubMed ID: 27822679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flashbacks and HPPD: A Clinical-oriented Concise Review.
    G Lerner A; Rudinski D; Bor O; Goodman C
    Isr J Psychiatry Relat Sci; 2014; 51(4):296-301. PubMed ID: 25841228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation.
    Lev-Ran S; Feingold D; Rudinski D; Katz S; Arturo LG
    Am J Addict; 2015 Apr; 24(3):197-199. PubMed ID: 25808913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation.
    Lev-Ran S; Feingold D; Frenkel A; Lerner AG
    J Dual Diagn; 2014; 10(2):79-83. PubMed ID: 25392249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinogen persisting perception disorder: what do we know after 50 years?
    Halpern JH; Pope HG
    Drug Alcohol Depend; 2003 Mar; 69(2):109-19. PubMed ID: 12609692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment.
    Doyle MA; Ling S; Lui LMW; Fragnelli P; Teopiz KM; Ho R; Di Vincenzo JD; Rosenblat JD; Gillissie ES; Nogo D; Ceban F; Jawad MY; McIntyre RS
    Expert Opin Drug Saf; 2022 Jun; 21(6):733-743. PubMed ID: 35426769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.
    Orsolini L; Papanti GD; De Berardis D; Guirguis A; Corkery JM; Schifano F
    Front Psychiatry; 2017; 8():240. PubMed ID: 29209235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use.
    Lev-Ran S; Feingold D; Goodman C; Lerner AG
    Am J Addict; 2017 Sep; 26(6):568-571. PubMed ID: 28654720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallucinogen persisting perception disorder: A literature review and three case reports.
    Skryabin VY; Vinnikova M; Nenastieva A; Alekseyuk V
    J Addict Dis; 2018; 37(3-4):268-278. PubMed ID: 31613183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On Perception and Consciousness in HPPD: A Systematic Review.
    Vis PJ; Goudriaan AE; Ter Meulen BC; Blom JD
    Front Neurosci; 2021; 15():675768. PubMed ID: 34456666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trip of a lifetime: hallucinogen persisting perceptual disorder.
    Anderson L; Lake H; Walterfang M
    Australas Psychiatry; 2018 Feb; 26(1):11-12. PubMed ID: 28836813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature.
    Ford H; Fraser CL; Solly E; Clough M; Fielding J; White O; Van Der Walt A
    Front Neurol; 2022; 13():878609. PubMed ID: 35599738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hallucinogen persisting perception disorder after ecstasy use].
    Hanck L; Schellekens AF
    Ned Tijdschr Geneeskd; 2013; 157(24):A5649. PubMed ID: 23759176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports.
    G Lerner A; Goodman C; Bor O; Lev-Ran S
    Isr J Psychiatry Relat Sci; 2014; 51(4):277-80. PubMed ID: 25841224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.
    Litjens RP; Brunt TM; Alderliefste GJ; Westerink RH
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1309-23. PubMed ID: 24933532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.
    Müller F; Kraus E; Holze F; Becker A; Ley L; Schmid Y; Vizeli P; Liechti ME; Borgwardt S
    Psychopharmacology (Berl); 2022 Jun; 239(6):1933-1943. PubMed ID: 35076721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flashback phenomena. Clinical and diagnostic dilemmas.
    Alarcon RD; Dickinson WA; Dohn HH
    J Nerv Ment Dis; 1982 Apr; 170(4):217-23. PubMed ID: 7062008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.